• 1
    Crosbie O, Alexander G. Hepatitis C links hepatologists, nephrologists and transplant surgeons. Transplantation 1999; 68: 1094–.
  • 2
    Cruzado JM, Torras J, Gil-Vernet S, Grinyó JM. Glomerulonephritis associated with hepatitis C virus infection after renal transplantation. Nephrol Dial Transplant 2000; 15 (Suppl. 8): 6567.
  • 3
    Cantarell MC, Charco R, Capdevila L et al. Outcome of hepatitis C virus-associated membranoproliferative glomerulonephritis after liver transplantation. Transplantation 1999; 68: 11311134.
  • 4
    Cruzado JM, Gil-Vernet S, Ercilla G et al. Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts. J Am Soc Nephrol 1996; 7: 24692475.
  • 5
    Cruzado JM, Carrera M, Torras J, Grinyó JM. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001; 1: 171178.
  • 6
    Pham HP, Feray C, Samuel D et al. Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. Kidney Int 1998; 54: 13111319.
  • 7
    Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995; 59: 14261431.
  • 8
    Natov SN, Pereira BJG. Management of hepatitis C infection in renal transplant recipients. Am J Transplant 2002; 2: 483490.
  • 9
    Casanovas-Taltavull T, Baliellas C et al. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation. Am J Gastroenterol 2001; 96: 11701177.
  • 10
    Morales JM, Campistol JM. Disease of the month: transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000; 11: 13431353.
  • 11
    Rostaing L, Chatelut E, Payen JL et al. Pharmacokinetics of αIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications. J Am Soc Nephrol 1998; 9: 23442348.